The bioavailability of non-nutrient plant factors: Dietary flavonoids and phyto-oestrogens

Proceedings of the Nutrition Society

Volumn 58, Issue 1, 1999, Pages 139-146

  Wiseman, Helen ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antioxidants; Bioavailability; Cancer; Flavonoids; Heart Disease; Phyto oestrogens

Indexed keywords

EQUOL; FLAVONOID; ISOFLAVONE DERIVATIVE; ISOPROSTANE; LIGNAN DERIVATIVE; LOW DENSITY LIPOPROTEIN; PHYTOESTROGEN;

ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CANCER PREVENTION; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; HEART PROTECTION; HUMAN; LIPID OXIDATION; STEROID BLOOD LEVEL; STEROL EXCRETION;

BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; DIET; ESTROGENS, NON-STEROIDAL; FLAVONOIDS; HUMANS; ISOFLAVONES; NEOPLASMS; PHYTOESTROGENS; PLANT PREPARATIONS; QUERCETIN;

BACTERIA (MICROORGANISMS);

EID: 0032937777     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS19990019     Document Type: Conference Paper

References (61)

1. Adlercreutz CHT, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, Hamalainen EK, Markkanen MH, Makela TH, Wahala KT, Hase TA & Fotsis T (1995) Soybean phytoestrogen intake and cancer risk. Journal of Nutrition 125, 757S-770S.
2. Adlercreutz H (1996) Lignans and isoflavonoids: epidemiology and possible role in prevention of cancer. In Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention, pp. 349-355 [JT Kumpulainen and JT Salonen, editors]. London: Royal Society of Chemistry.
3. Adlercreutz H, Markkanen H & Watanabe S (1993) Plasma concentrations of phytoestrogens in Japanese men. Lancet 342, 1209-1210.
4. Aziz AA, Edwards CA, Lean MEJ & Crozier A (1998) Absorption and excretion of conjugated flavonols, including quercetin-4′-O-β-glucoside and isorhamnetin-4′-O-β-glucoside by human volunteers after the consumption of onions. Free Radical Research (In the Press).
5. Bingham SA, Atkinson C, Liggins J, Bluck L & Coward A (1998) Plant oestrogens: where are we now? British Journal of Nutrition 79, 393-406.
6. Bowey EA, Rowland IR, Adlercreutz H, Sanders TAB & Wiseman H (1999) Inter-individual variation in soya metabolism: the role of habitual diet. Proceedings of the Nutrition Society 58 (In the Press).
7. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A & Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
8. Cassidy A (1996) Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proceedings of the Nutrition Society 55, 399-417.
9. Clarkson TB, Anthony MS & Hughes CL Jr (1995) Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends in Endocrinology and Metabolism 6, 11-16.
10. Cook NC & Samman S (1996) Flavonoids: chemistry, metabolism, cardioprotective effects and dietary sources. Journal of Nutritional Biochemistry 7, 66-76.
11. Crozier A, Lean MEJ, McDonald MS & Black C (1997) Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce and celery. Journal of Agricultural and Food Chemistry 45, 590-595.
12. Dean TS, O'Reilly J, Bowey E, Wiseman H, Rowland I & Sanders TAB (1998) The effects of soyabean isoflavones on plasma HDL concentrations in healthy male and female subjects. Proceedings of the Nutrition Society 57, 123A.
13. De Vries JHM, Janssen PLTMK, Hollman PCH, van Staveren WA & Katan MB (1997) Consumption of quercetin and kampferol in free-living subjects eating a variety of diets. Cancer Letters 114, 141-144.
14. De Whalley C, Rankin SM, Hoult JRS, Jesssup W & Leake DS (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochemical Pharmacology 39, 1743-1750.
15. Franke AA & Custer LJ (1996) Daidzein and genistein concentrations in human milk after soy consumption. Clinical Chemistry 42, 955-964.
16. Franke AA, Custer LJ, Wang W & Yang Shi C (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proceedings of the Society for Experimental Biology and Medicine 217, 263-273.
17. Golbitz P (1995) Traditional soy foods: processing and products. Journal of Nutrition 125, 570S-572S.
18. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1993a) Dietary antioxidant flavonoids and the risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007-1011.
19. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1994) Dietary antioxidant flavonoids and cancer risk in the Zutphen Elderly Study. Nutrition and Cancer 22, 175-184.
20. Hertog MGL & Hollman PCH (1996) Potential health effects of the dietary flavonol quercetin. European Journal of Clinical Nutrition 50, 63-71.
21. Hertog MGL, Hollman PCH & Katan MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry 40, 2379-2383.
22. Hertog MGL, Hollman PCH, Katan MB & Kromhout D (1993b) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer 20, 21-29.
23. Hertog MGL, Hollman PCH & Van de Putte B (1993c) Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. Journal of Agricultural and Food Chemistry 41, 1242-1246.
24. Hollman PCH (1997a) Determinants of the absorption of the dietary flavonoid quercetin in man. PhD Thesis, University of Wageningen, The Netherlands.
25. Hollman PCH (1997b) Bioavailability of flavonoids. European Journal of Clinical Nutrition 51, Suppl. 1, S66-S69.
26. Hollman PCH, de Vries JHM, van Leewen SD, Mengelers MJB & Katan MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. American Journal of Clinical Nutrition 62, 1276-1282.
27. Hollman PCH, van der Gaag MS, Mengelers MJB, van Trijp JMP, de Vries JHM & Katan MB (1996) Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radical Biology and Medicine 21, 703-707.
28. Hollman PCH, van Trijp JMP, Buysman MNCP, van der Gaag MS, Mengelers MJB, de Vries JHM & Katan MB (1997a) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Letters 418, 152-156.
29. Hollman PCH, van Trijp JMP, Mengelers MJB, de Vries JHM & Katan MB (1997b) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Letters 114, 139-140.
30. Horn-Ross PL, Barnes S, Kirk M, Coward L, Parsonnet J & Hiatt RA (1997) Urinary phytoestrogen levels in young women from a multiethnic population. Cancer Epidemiology, Biomarkers and Prevention 6, 339-345.
31. Karr SC, Lampe JW, Hutchins AM & Slavin JL (1997) Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. American Journal of Clinical Nutrition 66, 46-51.
32. Keli SO, Hertog MGL, Keskens EJM & Kromhout D (1996) Dietary flavonoids, antioxidant vitamins and incidence of stroke: The Zutphen study. Archives of Internal Medicine 156, 637-642.
33. Kelly GE, Joannou GE, Reeder AY, Nelson C & Waring MA (1995) The variable metabolic response to dietary isoflavones in humans. Proceedings of the Society for Experimental Biology and Medicine 208, 40-43.
34. King RA & Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. American Journal of Clinical Nutrition 67, 867-872.
35. Kirkman LM, Lampe JW, Campbell DR, Martini MC & Slavin JL (1995) Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutrition and Cancer 24, 1-12.
36. Lampe JW, Karr SC, Hutchins AM & Slavin JL (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proceedings of the Society for Experimental Biology and Medicine 217, 335-339.
37. Lapcik O, Hill M, Hampl R, Wahala K & Adlercreutz H (1998) Identification of isoflavonoids in beer. Steroids 63, 14-20.
38. Lu, L-JW, Grady JJ, Marshall MV, Ramanujam S & Anderson KE (1995) Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. Nutrition and Cancer 24, 311-323.
39. Lu L-JW, Lin S-N, Grady JJ, Nagamani M & Anderson KE (1996) Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. Nutrition and Cancer 26, 289-302.
40. Miksicek RJ (1995) Estrogenic flavonoids: structural requirements for biological activity. Proceedings of the Society for Experimental Biology and Medicine 208, 44-50.
41. Morton MS, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Blacklock N, Chan PSF, Cheng C, Lloyd S, Chieh-Ping W & Griffiths K (1997) Measurement and metabolism of isoflavonoids and lignans in the human male. Cancer Letters 114, 145-151.
42. Morton MS, Wilcox G, Wahlqvist ML & Griffiths K (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. Journal of Endocrinology 142, 251-259.
43. O'Reilly J, Dean TS, Bowey E, Rowland I, Sanders TAB & Wiseman H (1998) The influence of dietary isoflavones on markers of lipid peroxidation in healthy male and female volunteers. Proceedings of the Nutrition Society 57, 123A.
44. Paganga G & Rice-Evans CA (1997) The identification of flavonoids as glycosides in human plasma. FEBS Letters 401, 78-82.
45. Pettersson D, Aman P, Knudsen KEB, Lundin E, Zhang JX, Hallmans G, Harkonen H & Adlercreutz H (1996) Intake of rye bread by ileostomists increases ileal excretion of fiber polysaccharide components and organic acids but does not increase plasma or urine lignans and isoflavonoids. Journal of Nutrition 126, 1594-1600.
46. Raines EW & Ross R (1995) Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. Journal of Nutrition 125, 624S-630S.
47. Reinli K & Block G (1996) Phytoestrogen content of foods - a compendium of literature values. Nutrition and Cancer 26, 123-148.
48. Slavin J, Jacobs D & Marquait L (1997) Whole-grain consumption and chronic disease: Protective mechanisms. Nutrition and Cancer 27, 14-21.
49. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witzum JL (1989) Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 320, 915-924.
50. Tikkanen MJ, Wahala K, Ojala S, Vihma V & Adlercreutz H (1998) Effect of soybean phytoestrogen intake on low density lipoprotein resistance. Proceedings of the National Academy of Sciences 95, 3106-3110.
51. Thompson LU (1994) Antioxidant and hormone-mediated health benefits of whole grains. Critical Reviews in Food Science and Nutrition 34, 473-497.
52. Williams RL & Rutledge T (1998) Recent phytoestrogen research. Chemistry and Industry January, 14-16.
53. Wiseman H (1994) Tamoxifen: Molecular Basis of Use in Cancer Treatment and Prevention. Chichester: John Wiley.
54. Wiseman H (1996) Role of dietary phyto-oestrogens in the protection against cancer and heart disease. Biochemical Society Transactions 24, 795-800.
55. Wiseman H (1997) Dietary phytoestrogens: disease prevention versus potential hazards. Nutrition and Food Science 1, 32-38.
56. Wiseman H (1998) Phytochemicals (b) Epidemiological factors. In Encyclopedia of Human Nutrition [M Sadler, B Caballero and S Strain, editors]. London: Academic Press (In the Press).
57. Wiseman H & Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 313, 17-29.
58. Wiseman H & O'Reilly J (1997) Oestrogens as antioxidant cardioprotectants. Biochemical Society Transactions 25, 54-59.
59. Wiseman H, O'Reilly J, Lim P, Gamett AP, Huang W-C & Sanders TAB (1998) Antioxidant properties of the isoflavone phytoestrogen functional ingredient in soya products. In Functional Foods, The Consumer, The Products and The Evidence, pp. 80-86 [M Sadler and M Saltmarsh, editors]. Cambridge: Royal Society of Chemistry.
60. Wiseman H, Paganga G, Rice-Evans C & Halliwell B (1993) Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the protective action of tamoxifen? Biochemical Journal 292, 635-638.
61. Xu X, Harris KS, Wang H-J, Murphy PA & Hendrich S (1995) Unavailability of soybean isoflavones depends upon gut microflora in women. Journal of Nutrition 125, 2307-2315.